{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "63102-110",
      "generic_name": "DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE",
      "labeler_name": "ACTIPHARMA, LLC",
      "brand_name": "ACTIDOM DMX",
      "active_ingredients": [
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "30 mg/5mL"
        },
        {
          "name": "GUAIFENESIN",
          "strength": "200 mg/5mL"
        },
        {
          "name": "PHENYLEPHRINE HYDROCHLORIDE",
          "strength": "10 mg/5mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "63102-110-16",
          "description": "474 mL in 1 BOTTLE, PLASTIC (63102-110-16)",
          "marketing_start_date": "20150813",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "ACTIPHARMA, LLC"
        ],
        "rxcui": [
          "1364914"
        ],
        "spl_set_id": [
          "0166322e-7dbb-4658-a5c5-1d0525bb7655"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000193956",
          "N0000008867",
          "N0000009560"
        ],
        "pharm_class_epc": [
          "Expectorant [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Respiratory Secretion Viscosity [PE]",
          "Increased Respiratory Secretions [PE]"
        ],
        "unii": [
          "9D2RTI9KYH",
          "495W7451VQ",
          "04JA59TNSJ"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "SOLUTION",
      "spl_id": "07838a85-4ddc-470d-a344-001587f2d904",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20150813",
      "product_id": "63102-110_07838a85-4ddc-470d-a344-001587f2d904",
      "application_number": "M012",
      "brand_name_base": "ACTIDOM DMX",
      "pharm_class": [
        "Adrenergic alpha1-Agonists [MoA]",
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]",
        "alpha-1 Adrenergic Agonist [EPC]"
      ]
    }
  ]
}